Sheets Smith Wealth Management Amgen Inc Transaction History

Sheets Smith Wealth Management

$807 Million
Q3 2024

A detailed history of Sheets Smith Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Sheets Smith Wealth Management holds 20,692 shares of AMGN stock, worth $5.8 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

20,692

Previous 15,947 29.75%

Holding current value

$5.8 Million

Previous $4.98 Million 33.82%

% of portfolio

0.83%

Previous 0.6%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $1.47 Million - $1.6 Million	4,745 Added 29.75%	20,692 $6.67 Million
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $774,324 - $941,006	2,947 Added 22.67%	15,947 $4.98 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $56,462 - $68,157	210 Added 1.64%	13,000 $3.7 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $132,964 - $149,999	-520 Reduced 3.91%	12,790 $3.68 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $2,186 - $2,714	10 Added 0.08%	13,310 $3.58 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $8,142 - $9,628	38 Added 0.29%	13,300 $2.95 Million
Q1 2023 May 26, 2023	BUY	$225.79 - $275.2 $2.94 Million - $3.58 Million	13,020 Added 5380.17%	13,262 $3.21 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $2.97 Million - $3.63 Million	-13,174 Reduced 98.2%	242 $58,000
Q4 2022 Mar 08, 2023	SELL	$229.03 - $291.01 $687 - $873	-3 Reduced 0.02%	13,416 $3.52 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $26,935 - $30,378	-120 Reduced 0.89%	13,419 $3.03 Million
Q2 2022 Jul 27, 2022	SELL	$230.71 - $256.74 $58,369 - $64,955	-253 Reduced 1.83%	13,539 $3.29 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $18,857 - $20,861	-86 Reduced 0.62%	13,792 $3.34 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $90,689 - $103,785	456 Added 3.4%	13,878 $3.12 Million
Q3 2021 Oct 15, 2021	BUY	$212.27 - $248.7 $25,896 - $30,341	122 Added 0.92%	13,422 $2.85 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $92,731 - $102,878	397 Added 3.08%	13,300 $3.24 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $113,174 - $131,886	510 Added 4.12%	12,903 $3.21 Million
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $242,561 - $288,848	1,121 Added 9.94%	12,393 $2.85 Million
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $4,693 - $5,219	20 Added 0.18%	11,272 $2.87 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $1.35 Million - $1.66 Million	6,826 Added 154.23%	11,252 $2.65 Million
Q1 2020 Apr 28, 2020	SELL	$182.24 - $241.7 $11,116 - $14,743	-61 Reduced 1.36%	4,426 $897,000
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $13,055 - $16,780	-69 Reduced 1.51%	4,487 $1.08 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $30,817 - $36,925	-177 Reduced 3.74%	4,556 $882,000
Q2 2019 Jul 12, 2019	SELL	$166.7 - $195.41 $15,002 - $17,586	-90 Reduced 1.87%	4,733 $872,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $10,490 - $11,825	-58 Reduced 1.19%	4,823 $916,000
Q4 2018 Jan 11, 2019	SELL	$178.4 - $208.25 $4,816 - $5,622	-27 Reduced 0.55%	4,881 $950,000
Q3 2018 Oct 15, 2018	BUY	$185.29 - $208.89 $555 - $626	3 Added 0.06%	4,908 $1.02 Million
Q2 2018 Jul 26, 2018	SELL	$166.05 - $186.51 $16,937 - $19,024	-102 Reduced 2.04%	4,905 $905,000
Q1 2018 Apr 09, 2018	BUY	$169.43 - $198.0 $4,066 - $4,752	24 Added 0.48%	5,007 $854,000
Q4 2017 Jan 12, 2018	BUY	$168.79 - $188.59 $25,487 - $28,477	151 Added 3.13%	4,983 $867,000
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $808,345 - $922,912	4,832	4,832 $901,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Amgen Inc Transaction History